PULMONX CORPORATION Inventory, Work in Process, Net of Reserves
PULMONX CORPORATION (LUNG) had Inventory, Work in Process, Net of Reserves of $781.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2026-08-04
- 2026-06-30: Inventory, Work in Process, Net of Reserves $781.00K.
- 2026-03-31: Inventory, Work in Process, Net of Reserves $712.00K.
- 2025-12-31: Inventory, Work in Process, Net of Reserves $529.00K.
- 2025-09-30: Inventory, Work in Process, Net of Reserves $577.00K.
| Period end | Inventory, Work in Process, Net of Reserves |
|---|---|
| 2026-06-30 | $781.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $712.00K 10-Q · filed 2026-05-04 |
| 2025-12-31 | $529.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $577.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $562.00K 10-Q · filed 2025-08-01 |
| 2025-03-31 | $503.00K 10-Q · filed 2025-05-02 |
| 2024-12-31 | $457.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $369.00K 10-Q · filed 2024-11-01 |
| 2024-06-30 | $387.00K 10-Q · filed 2024-08-02 |
| 2024-03-31 | $440.00K 10-Q · filed 2024-05-03 |
| 2023-12-31 | $427.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $541.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $636.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $473.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $386.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $550.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $784.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $750.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $518.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $708.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $382.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $313.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $227.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $328.00K 10-Q · filed 2020-11-13 |
| 2019-12-31 | $180.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |